PROPYLTHIOURACIL tablet United States - English - NLM (National Library of Medicine)

propylthiouracil tablet

quagen pharmaceuticals llc - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil is indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option. - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole. propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

Propylthiouracil 50mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

propylthiouracil 50mg tablets

alliance healthcare (distribution) ltd - propylthiouracil - oral tablet - 50mg

Propylthiouracil 50 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

propylthiouracil 50 mg tablets

halewood chemicals limited - propylthiouracil - tablet - 50 milligram(s) - thiouracils; propylthiouracil